Decision to list Nitrolingual Pump Spray and Azamun tablets
25 November 2014
PHARMAC is pleased to announce the approval of an agreement with Douglas Pharmaceuticals Limited for the the supply of glyceryl trinitrate oral spray (“Nitrolingual Pump Spray”) and a 25 mg azathioprine tablet (“Azamun”).
In summary, this decision will result in:
- Nitrolingual Pump Spray being fully funded for patients from 1 May 2015; and
- Azamun 25 mg tablets being fully funded for patients from 1 February 2015.
Details of the decision
We appreciate all of the feedback that we received and acknowledge the time people took to respond. All consultation responses received by 5 November 2014 were considered in their entirety in making a decision on the proposed changes. All responses were supportive of the proposal, and the following issues were raised in relation to specific aspects of the proposal:
|Request for an earlier listing date for Nitrolingual Pump Spray.||1 May 2015 is the earliest date from which the supplier can guarantee supply.|
If you have any questions about this decision, you can email us at email@example.com or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.
Last updated: 16 February 2016